Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Public ClinicalTrials.gov record NCT00557830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Phase IIb Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma (RCC)
Study identification
- NCT ID
- NCT00557830
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Accelerated Community Oncology Research Network
- Other
- Enrollment
- 12 participants
Conditions and interventions
Conditions
Interventions
- Sorafenib Escalated Dose Drug
- Sorafenib Standard Dose Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2007
- Primary completion
- Mar 31, 2011
- Completion
- Mar 31, 2011
- Last update posted
- Jul 17, 2013
2008 – 2011
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clopton Clinic | Jonesboro | Arkansas | 72401 | — |
| Wilshire Oncology Medical Group, Inc. | La Verne | California | 91750 | — |
| Advanced Medical Specialties | Miami | Florida | 33176 | — |
| Northeast Georgia Cancer Care | Athens | Georgia | 30607 | — |
| Peachtree Hematology Oncology Consultants | Atlanta | Georgia | 30309 | — |
| Central Georgia Cancer Care | Macon | Georgia | 31201 | — |
| Northwest Georgia Oncology Centers | Marietta | Georgia | 30060 | — |
| Mid-Illinois Hematology and Oncology Associates, Ltd. | Normal | Illinois | 61761 | — |
| Hematology Oncology Centers of the Northern Rockies | Billings | Montana | 59101 | — |
| Gaston Hematology and Oncology | Gastonia | North Carolina | 28054 | — |
| Pacific Oncology, PC | Beaverton | Oregon | 97006 | — |
| The Lancaster Cancer Center, Ltd | Lancaster | Pennsylvania | 17605 | — |
| The West Clinic | Memphis | Tennessee | 38120 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00557830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2013 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00557830 live on ClinicalTrials.gov.